Abbott India Limited (ABBOTINDIA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Abbott India Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Abbott India Limited (ABBOTINDIA) financial obligations for a breakdown of total debt and financial obligations.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Soochow Securities Co Ltd
SHG:601555
|
0.336x |
|
Guangzhou Haige Communications Group Incorporated Co
SHE:002465
|
-0.018x |
|
Genpact Limited
NYSE:G
|
0.112x |
|
Jiangsu Financial Leasing Co Ltd Class A
SHG:600901
|
-0.003x |
|
QMMM Holdings Limited Ordinary Shares
NASDAQ:QMMM
|
-0.103x |
|
Yonyou Network Technology Co Ltd
SHG:600588
|
-0.001x |
|
Marfrig Global Foods S.A.
SA:MRFG3
|
0.234x |
|
Century Aluminum Company
NASDAQ:CENX
|
0.108x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Abbott India Limited market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs42.33 Billion ≈ $457.80 Million |
Rs10.12 Billion ≈ $109.43 Million |
0.239x | -27.10% |
| 2024-03-31 | Rs36.99 Billion ≈ $400.02 Million |
Rs12.13 Billion ≈ $131.16 Million |
0.328x | +17.02% |
| 2023-03-31 | Rs31.89 Billion ≈ $344.83 Million |
Rs8.93 Billion ≈ $96.62 Million |
0.280x | -16.63% |
| 2022-03-31 | Rs28.20 Billion ≈ $304.95 Million |
Rs9.48 Billion ≈ $102.49 Million |
0.336x | +20.33% |
| 2021-03-31 | Rs26.02 Billion ≈ $281.41 Million |
Rs7.27 Billion ≈ $78.59 Million |
0.279x | +8.47% |
| 2020-03-31 | Rs24.32 Billion ≈ $262.98 Million |
Rs6.26 Billion ≈ $67.71 Million |
0.257x | +3.61% |
| 2019-03-31 | Rs20.09 Billion ≈ $217.22 Million |
Rs4.99 Billion ≈ $53.98 Million |
0.248x | +175.47% |
| 2018-03-31 | Rs16.93 Billion ≈ $183.07 Million |
Rs1.53 Billion ≈ $16.51 Million |
0.090x | -59.27% |
| 2017-03-31 | Rs13.87 Billion ≈ $149.99 Million |
Rs3.07 Billion ≈ $33.22 Million |
0.222x | +6.50% |
| 2016-03-31 | Rs11.96 Billion ≈ $129.30 Million |
Rs2.49 Billion ≈ $26.89 Million |
0.208x | -9.21% |
| 2015-03-31 | Rs9.38 Billion ≈ $101.39 Million |
Rs2.15 Billion ≈ $23.23 Million |
0.229x | +53.60% |
| 2014-03-31 | Rs8.33 Billion ≈ $90.09 Million |
Rs1.24 Billion ≈ $13.44 Million |
0.149x | -4.81% |
| 2013-03-31 | Rs6.47 Billion ≈ $69.96 Million |
Rs1.01 Billion ≈ $10.96 Million |
0.157x | +254.26% |
| 2012-03-31 | Rs5.44 Billion ≈ $58.85 Million |
Rs240.66 Million ≈ $2.60 Million |
0.044x | -70.68% |
| 2011-03-31 | Rs3.05 Billion ≈ $33.03 Million |
Rs460.64 Million ≈ $4.98 Million |
0.151x | +10.24% |
| 2010-03-31 | Rs2.72 Billion ≈ $29.37 Million |
Rs371.57 Million ≈ $4.02 Million |
0.137x | -65.29% |
| 2009-03-31 | Rs2.21 Billion ≈ $23.93 Million |
Rs872.13 Million ≈ $9.43 Million |
0.394x | +196.26% |
| 2008-03-31 | Rs2.31 Billion ≈ $24.98 Million |
Rs307.40 Million ≈ $3.32 Million |
0.133x | -19.72% |
| 2007-03-31 | Rs2.46 Billion ≈ $26.58 Million |
Rs407.40 Million ≈ $4.41 Million |
0.166x | -2.57% |
| 2006-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs368.20 Million ≈ $3.98 Million |
0.170x | -53.15% |
| 2005-03-31 | Rs1.88 Billion ≈ $20.36 Million |
Rs683.70 Million ≈ $7.39 Million |
0.363x | -- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more